BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12945880)

  • 1. Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
    Kopp CW; Steiner S; Priglinger U; Christ G; Probst P; Maurer G; Minar E; Huber K
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):379-86. PubMed ID: 12945880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris.
    Marco J; Ariëns RA; Fajadet J; Bossi IM; Marco I; Bernies M; Romano SM; Donatelli F; Brambilla GM; Somalvico F; Mari D; Gregorini L
    Am J Cardiol; 2000 Mar; 85(5):527-31. PubMed ID: 11078261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
    Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
    Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimal platelet inhibition therapy in unstable angina pectoris and after coronary interventions].
    Niessner A; Niessner H; Huber K
    Herz; 2001 Apr; 26 Suppl 1():36-41. PubMed ID: 11349625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
    Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
    Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for low-molecular weight heparin in coronary stenting.
    Zidar JP
    Am Heart J; 1997 Nov; 134(5 Pt 2):S81-7. PubMed ID: 9396639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
    Leon MB; Baim DS; Popma JJ; Gordon PC; Cutlip DE; Ho KK; Giambartolomei A; Diver DJ; Lasorda DM; Williams DO; Pocock SJ; Kuntz RE
    N Engl J Med; 1998 Dec; 339(23):1665-71. PubMed ID: 9834303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin.
    Wilson SH; Rihal CS; Bell MR; Velianou JL; Holmes DR; Berger PB
    Am J Cardiol; 1999 Apr; 83(7):1006-11. PubMed ID: 10190510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary stenting (Cordis) without anticoagulation.
    Park SW; Park SJ; Hong MK; Kim JJ; Cho SY; Jang YS; Kim KB; Kim KS; Oh DJ; Oh BH; Kang JC
    Am J Cardiol; 1997 Apr; 79(7):901-4. PubMed ID: 9104903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures.
    Gregorini L; Marco J; Fajadet J; Bernies M; Cassagneau B; Brunel P; Bossi IM; Mannucci PM
    J Am Coll Cardiol; 1997 Jan; 29(1):13-20. PubMed ID: 8996289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation.
    Nakamura S; Hall P; Gaglione A; Tiecco F; Di Maggio M; Maiello L; Martini G; Colombo A
    J Am Coll Cardiol; 1997 Jan; 29(1):21-7. PubMed ID: 8996290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Blankenberg S; Alessi MC; Bickel C; Rupprecht HJ; Schnabel R; Lubos E; Münzel T; Peetz D; Nicaud V; Juhan-Vague I; Tiret L;
    J Thromb Haemost; 2007 Mar; 5(3):475-82. PubMed ID: 17204132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
    Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
    Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Popma JJ; Berger P; Ohman EM; Harrington RA; Grines C; Weitz JI
    Chest; 2004 Sep; 126(3 Suppl):576S-599S. PubMed ID: 15383485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience.
    Anzuini A; Rosanio S; Legrand V; Tocchi M; Coppi R; Bonnier H; Sheiban I; Kulbertus HE; Chierchia SL
    J Am Coll Cardiol; 1998 Feb; 31(2):281-8. PubMed ID: 9462568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute occlusion, bleeding complications, hospital stay and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regimen.
    Fernández-Avilés F; Alonso JJ; Durán JM; Gimeno F; Muñoz JC; de la Fuente L; San Román JA
    J Am Coll Cardiol; 1996 Jan; 27(1):22-9. PubMed ID: 8522699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of coronary stenting for unstable versus stable angina pectoris.
    Marzocchi A; Piovaccari G; Marrozzini C; Ortolani P; Palmerini T; Branzi A; Magnani B
    Am J Cardiol; 1997 May; 79(10):1314-8. PubMed ID: 9165149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.